Amylyx Pharmaceuticals Inc (AMLX NASDAQ) stock market data APIs
$11.8743
0.09(0.8%)
as of September 15, 2025
Try our APIs with
free plan!
Amylyx Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Prev. Close
11.8743
Open
11.9658
High
12.0355
Low
11.4451
52 wk Range
2.6-12.25
Market Cap
1 243 M
Shares Outstanding
107 M
Revenue
-249 000
EPS
-0.46
Beta
-0.439
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Amylyx Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Amylyx Pharmaceuticals Inc data using free add-ons & libraries
Get Amylyx Pharmaceuticals Inc Fundamental Data
Amylyx Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: -249 000
- EBITDA: -196 296 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.46
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Amylyx Pharmaceuticals Inc News
New
Amylyx Pharmaceuticals prices $175M public offering
* Amylyx Pharmaceuticals (NASDAQ:AMLX [https://seekingalpha.com/symbol/AMLX]) priced [https://seekingalpha.com/pr/20227278-amylyx-pharmaceuticals-announces-pricing-of-175-million-underwritten-public...
Amylyx announces proposed public offering of common stock
* Amylyx Pharmaceuticals (NASDAQ:AMLX [https://seekingalpha.com/symbol/AMLX]) on Tuesday said it has started an underwritten public offering of its common stock, with all shares to be sold by the co...
Amylyx drops clinical program for neuro disorder after trial readout
[Isolated Document Red X Error Cancelled] Anton Zacon/iStock via Getty Images * Amylyx Pharmaceuticals (NASDAQ:AMLX [https://seekingalpha.com/symbol/AMLX]) announced on Wednesday that it has decide...
Amylyx Pharmaceuticals discontinues ORION program for AMX0035 in PSP
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), currently trading at $9.16 and showing a remarkable 330% return over the past year, announced Wednesday that it is discontinuing the ORION program evaluatin...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
